OPKO Health Inc (STU:XCY)

€ 1.427 -0.039 (-2.66%) Market Cap: 955.43 Mil Enterprise Value: 1.06 Bil PE Ratio: 0 PB Ratio: 0.72 GF Score: 41/100

Q3 2024 OPKO Health Inc Earnings Call Transcript
Nov 07, 2024

€1.3 (-2.40%)

Earnings
Q2 2024 OPKO Health Inc Earnings Call Transcript
Aug 07, 2024

€1.22 (+3.82%)

Earnings
Q1 2024 OPKO Health Inc Earnings Call Transcript
May 07, 2024

€1.19 (-0.72%)

Earnings
Q4 2023 OPKO Health Inc Earnings Call Transcript
Feb 27, 2024

€0.9082 (+2.30%)

Earnings
OPKO Health Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2023 OPKO Health Inc Earnings Call Transcript
Nov 06, 2023

€1.23 (-0.98%)

Earnings
Q2 2023 OPKO Health Inc Earnings Call Transcript
Aug 03, 2023

€1.59

Earnings
Q1 2023 OPKO Health Inc Earnings Call Transcript
May 03, 2023

€1.34 (-2.45%)

Earnings
OPKO Health Inc R&D Day (Virtual) Transcript
Mar 20, 2023
Q4 2022 OPKO Health Inc Earnings Call Transcript
Feb 23, 2023

€1.02 (+2.31%)

Earnings
OPKO Health Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
Q3 2022 OPKO Health Inc Earnings Call Transcript
Nov 08, 2022

€1.85 (+4.70%)

Earnings
Q2 2022 OPKO Health Inc Earnings Call Transcript
Aug 04, 2022

€2.33 (-2.94%)

Earnings
Q1 2022 OPKO Health Inc Earnings Call Transcript
May 09, 2022

€2.35 (-4.06%)

Earnings
Q4 2021 OPKO Health Inc Earnings Call Transcript
Feb 24, 2022

€2.61 (-3.33%)

Earnings
OPKO Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Q3 2021 OPKO Health Inc Earnings Call Transcript
Oct 28, 2021

€3.02 (-1.89%)

Earnings
Q2 2021 OPKO Health Inc Earnings Call Transcript
Jul 29, 2021

€3.18 (+1.92%)

Earnings
Q1 2021 OPKO Health Inc Earnings Call Transcript
Apr 28, 2021

€3.43 (-3.36%)

Earnings
Q4 2020 OPKO Health Inc Earnings Call Transcript
Feb 18, 2021

€4.48 (-1.56%)

Earnings
OPKO Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
OPKO Health Inc at Piper Sandler Healthcare Conference (Virtual) - Fireside Chat Pre-Recording Session Transcript
Nov 17, 2020
Q3 2020 OPKO Health Inc Earnings Call Transcript
Oct 29, 2020

€2.64

Earnings
Q2 2020 OPKO Health Inc Earnings Call Transcript
Jul 30, 2020

€4.79 (+2.27%)

Earnings
OPKO Health Inc Annual Shareholders Meeting Transcript
Jun 25, 2020
Q1 2020 OPKO Health Inc Earnings Call Transcript
May 06, 2020

€2.13 (-3.88%)

Earnings
Q4 2019 OPKO Health Inc Earnings Call Transcript
Feb 26, 2020

€1.29 (-6.13%)

Earnings
OPKO Health Inc at JPMorgan Healthcare Conference Transcript
Jan 15, 2020
OPKO Health Inc at Piper Jaffray Healthcare Conference Transcript
Dec 04, 2019
Q3 2019 OPKO Health Inc Earnings Call Transcript
Nov 05, 2019

€1.41 (+9.30%)

Earnings
Q2 2019 OPKO Health Inc Earnings Call Transcript
Aug 07, 2019

€1.76 (+2.92%)

Earnings
OPKO Health Inc Annual Shareholders Meeting Transcript
Jun 20, 2019
Q1 2019 OPKO Health Inc Earnings Call Transcript
May 07, 2019

€2.16 (+1.89%)

Earnings
Q4 2018 OPKO Health Inc Earnings Call Transcript
Feb 27, 2019

€2.44 (-1.61%)

Earnings

OPKO Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 08:00PM GMT

Release Date Price: €3.87 (-2.91%)

Transcript

Adi Jayanthi

JPMorgan - Analyst

Hi, everyone. Good afternoon. Thank you all for joining us today for our conversation with OPKO Health. My name is Adi Jayanthi from the JPMorgan's Healthcare Investment Banking team. I'm really excited today to introduce the management team at OPKO Health.

So with us today, we have Dr. Phil Frost, CEO and Chairman of OPKO; Steve Rubin, Executive Vice President, Administration; Adam Logal, Senior Vice President and CFO; Jon Cohen, Senior Vice President of OPKO and Executive Chairman of BioReference Laboratories; and Katherine Stueland, President and CEO of GeneDx. So welcome to all of you and thank you very much for joining us here at the conference.

Maybe before we get going, obviously, you guys are a diversified business and would love to just get an overview of the company and any particular areas that you'd like to highlight.

Jon R. Cohen

OPKO Health, Inc. - Senior VP & Director, Executive Chairman of BioReference Laboratories

Sure. So I'll give you a little brief overview for the BioReference piece

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.